IQVIA Holdings Inc. (IQV)

191,81 +0,92 (+0,48 %) À la clôture : 04:03PM EDT

IQVIA Holdings Inc.

2400 Ellis Road
Durham, NC 27703
United States
919 998 2000
https://www.iqvia.com

Secteur(s): Healthcare
Secteur d’activité: Diagnostics & Research
Employés à temps plein: 86 000

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Ari Bousbib	Chairman, Pres & CEO	8,33M	S.O.	1961
Mr. Ronald E. Bruehlman	Exec. VP & CFO	2,38M	S.O.	1961
Mr. Eric M. Sherbet	Exec. VP, Gen. Counsel & Sec.	1,33M	S.O.	1964
Mr. Constantinos Panagos	Pres of R&D Solutions	1,37M	S.O.	1974
Mr. Kevin C. Knightly	Pres of Corp. Strategy & Enterprise Networks	1,32M	S.O.	1961
Ms. Keriann Cherofsky	Sr. VP, Corp. Controller & Principal Accounting Officer	S.O.	S.O.	1984
Dr. Jeffrey A. Spaeder	Sr. VP, Global Chief Medical & Scientific Officer	S.O.	S.O.	S.O.
Mr. Karl Guenault	Sr. VP & Chief Information Officer	S.O.	S.O.	S.O.
Mr. Nicholas Childs	Sr. VP of Investor Relations & Treasury	S.O.	S.O.	S.O.
Ms. Trudy Stein	Chief HR Officer & Exec. VP	S.O.	S.O.	S.O.

Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and decentralized clinical trials, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was incorporated in 2016 and is headquartered in Durham, North Carolina.

Gouvernance d’entreprise

L’ISS Governance QualityScore de IQVIA Holdings Inc. en date du 1 mars 2023 est 9. Les scores principaux sont Audit : 6; Société : 9; Droits des actionnaires : 6; Compensation : 9.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.